Searching for Mpox on surfaces and in the air

Between October 2024 and January 2025, the UK identified eight cases of Clade Ib Monkeypox virus (MPXV), with seven patients admitted to high consequence infectious disease (HCID) centres. A comprehensive environmental sampling study was conducted to assess the extent of MPXV contamination in isolation rooms and anterooms, focusing on both air and surface samples.

Continue reading

Comparing SARS-CoV-2 air and surface contamination in the first vs. second waves

Way back during the first wave of COVID-19 (April 2020), we got our swabs out and sampled surfaces and air across a range of settings in the hospital. This cross-sectional study identified SARS-CoV-2 RNA on a rather startling 52% of surfaces and 45% of air samples collected from across the hospital and some public areas. During the second wave (January 2021), we undertook a similar exercise, and identified a vastly different level of contamination with SARS-CoV-2 RNA: 5% of surfaces and 4% of air samples. What had changed between April 2020 and January 2021 to explain this difference? A whole host of things, and we don’t know for sure – but I suspect that improved testing availability and the introduction of masks for staff and patients were the most important factors.

Continue reading